Literature DB >> 12918140

Relationship between nuclear morphometry, DNA content and resectability of pancreatic cancer.

Yin-Cheng He1, Wei Peng, Jian-Guo Qiao, Jun Cao, Ji-Wei Chen.   

Abstract

AIM: To investigate the association of nuclear morphometry and DNA content with resectability of pancreatic cancer.
METHODS: A total of 36 patients with pancreatic adenocarcinoma were divided into resectable group and unresectable group. The nuclear morphometry and DNA contents of tumor cells were analyzed by IBAS autoimagine analyzer from paraffin-embedded materials. Localization size, histological type and grade, and clinical stage of the tumor were evaluated. Factors influencing resectability of pancreatic cancer were investigated using stepwise regression analysis.
RESULTS: Statistical significance was found in nuclear DNA content (integrated optical density, IOD) of tumor cells (1.64+/-0.41 vs 2.96+/-0.55), DNA ploidy, ages (46.5+/-5.3 years vs 58.6+/-0.7 years) and tumor volumes (298.1+/-101.5 cm(3) vs 634.7+/-512.5 cm(3)) in both groups (P<0.05), and no difference was found in the nuclear morphometry (P>0.05). The rates of diploid/tetraploid and aneuploid were 66.7 % and 33.3 % in resectable group respectively, and 38.9 % and 62.1 % in unresectable group, respectively (P<0.05). IOD (X(12)), ploidy status (X(12)) and clinical stage (X(3)) were radical resectable indicators with statistical significance. The regression equation for resectability was Y=-9.2053+3.5428X(12)+2.5390X(13)-2.3001X(3) (RR=0.8780, P<0.01).
CONCLUSION: There is a high correlation between resectability of pancreatic cancers and their DNA contents, DNA ploidy status and clinical stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918140      PMCID: PMC4611563          DOI: 10.3748/wjg.v9.i8.1863

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.

Authors:  N B Merchant; K C Conlon; P Saigo; E Dougherty; M F Brennan
Journal:  J Am Coll Surg       Date:  1999-04       Impact factor: 6.113

2.  Prognostic factors in the operative treatment of ductal pancreatic carcinoma.

Authors:  C Gebhardt; W Meyer; M Reichel; P H Wünsch
Journal:  Langenbecks Arch Surg       Date:  2000-01       Impact factor: 3.445

3.  Quality of life and outcomes after pancreaticoduodenectomy.

Authors:  J J Huang; C J Yeo; T A Sohn; K D Lillemoe; P K Sauter; J Coleman; R H Hruban; J L Cameron
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

4.  DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancer.

Authors:  Russell G Postier; Megan R Lerner; Stan A Lightfoot; Rick Vannarath; Mary M Lane; Jay S Hanas; Daniel J Brackett
Journal:  J Histochem Cytochem       Date:  2003-03       Impact factor: 2.479

5.  Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.

Authors:  Takanori Yoshida; Toshifumi Matsumoto; Atsushi Sasaki; Yuji Morii; Masanori Aramaki; Seigo Kitano
Journal:  Arch Surg       Date:  2002-01

6.  Prognostic significance of the combination of biological parameters in breast cancer.

Authors:  Shinichi Tsutsui; Shinji Ohno; Shigeru Murakami; Akemi Kataoka; Junko Kinoshita; Yoichi Hachitanda
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

7.  Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck.

Authors:  B F El-Rayes; Z Maciorowski; H Pietraszkiewicz; J F Ensley
Journal:  Otolaryngol Head Neck Surg       Date:  2003-02       Impact factor: 3.497

8.  Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.

Authors:  Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

10.  Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability.

Authors:  Carlo Catalano; Andrea Laghi; Francesco Fraioli; Federica Pediconi; Alessandro Napoli; Massimiliano Danti; Isabella Reitano; Roberto Passariello
Journal:  Eur Radiol       Date:  2002-07-18       Impact factor: 5.315

View more
  2 in total

Review 1.  Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature.

Authors:  Marek Durlik; Julia Tuchalska-Czuroń
Journal:  Prz Gastroenterol       Date:  2014-12-30

2.  Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.

Authors:  Nikolas Tsavaris; Nicolaos Kavantzas; Kostantinos Tsigritis; Ioannis D Xynos; Nikitas Papadoniou; Andreas Lazaris; Christos Kosmas; George Agrogiannis; Anna Dokou; Evangelos Felekouras; Efstathios Antoniou; Aris Polyzos; John Sarantonis; Heracles Tsipras; Gavrilos Karatzas; Alexandros Papalambros; Efstratios S Patsouris
Journal:  BMC Cancer       Date:  2009-07-31       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.